An analyst stated SpaceX shares may trade like Tesla ‘on steroids’ after its IPO, implying accelerated outperformance compared with Tesla’s initial public offering. This outlook could shift investor focus and capital allocation away from Tesla stock toward SpaceX’s market debut.

Qualcomm’s CEO signaled that its robotics segment could scale meaningfully within two years, supported by the launch of the Dragonwing robotics processor. Industry estimates forecast a $370 billion general-purpose robotics market by 2040 and a $9 trillion humanoid robotics total addressable market by 2050, underscoring significant growth stakes.

Tesla’s Optimus humanoid robot faces intensified competition as Qualcomm advances dedicated robotics processors and Nvidia expands its ecosystem strategy. Investor scrutiny of these rival platforms and chip developments could influence Tesla’s valuation if external suppliers or competing ecosystems gain market traction.